Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome

Antiviral Res. 2014 Sep:109:64-7. doi: 10.1016/j.antiviral.2014.06.010. Epub 2014 Jun 25.

Abstract

In this work we have addressed the effect of synthetic, non-infectious, RNA transcripts, mimicking structural domains of the non-coding regions (NCRs) of the foot-and-mouth disease virus (FMDV) genome on the infection of mice with Rift Valley fever virus (RVFV). Groups of 5 mice were inoculated intraperitoneally (i.p.) with 200 μg of synthetic RNA resembling the 5'-terminal S region, the internal ribosome entry site (IRES) or the 3'-NCR of the FMDV genome. RNA inoculation was performed 24h before (-24 h), 24 h after (+24 h) or simultaneously to the challenge with a lethal dose of RVFV. Administration of the IRES RNA afforded higher survival rates than administration of S or 3'NCR transcripts either at -24h or +24h after challenge. In contrast, when RNA inoculation and viral challenge were performed simultaneously, all mice survived in both IRES- and 3'NCR-inoculated groups, with an 80% survival in mice receiving the S RNA. Among survivors, a complete correlation between significant anti-RVFV circulating antibody titers and resistance to a second lethal challenge with the virus was observed, supporting a limited viral replication in the RNA-inoculated animals upon the first challenge. All three RNA transcripts were able to induce the production of systemic antiviral and pro-inflammatory cytokines. These data show that triggering of intracellular pathogen sensing pathways constitutes a promising approach towards development of novel RVF preventive or therapeutic strategies.

Keywords: Foot and mouth disease virus; Innate immunity; Non coding RNA regions; Rift Valley fever.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / immunology
  • Cross Protection
  • Foot-and-Mouth Disease Virus / genetics*
  • Foot-and-Mouth Disease Virus / immunology
  • Genome, Viral
  • Humans
  • Interferons / administration & dosage*
  • Mice
  • Mice, Inbred BALB C
  • RNA, Viral / administration & dosage
  • RNA, Viral / chemical synthesis
  • RNA, Viral / genetics
  • RNA, Viral / immunology*
  • Rift Valley Fever / immunology
  • Rift Valley Fever / prevention & control*
  • Rift Valley Fever / virology
  • Rift Valley fever virus / immunology*
  • Rift Valley fever virus / physiology
  • Vaccination
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / chemical synthesis
  • Viral Vaccines / genetics
  • Viral Vaccines / immunology*
  • Virus Replication

Substances

  • Antibodies, Viral
  • RNA, Viral
  • Viral Vaccines
  • Interferons